You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
  1. PLASMA & BIOTHERAPIES - 30-08-2014

    Kedrion announces the launch of Plasmaclot™ on the Mexican market

    Kedrion launches Plasmaclot™ in Mexico. Plasma-derived coagulation factor treats hemophilia A

    read more 
For more information please contact: